PTV Margins in MR-guided and Beam-gated SBRT of Liver Metastases: GTV Dose Escalation Can Reduce the Required PTV.

IF 3.2 3区 医学 Q2 ONCOLOGY
I Wahlstedt, E van der Bijl, K Boye, S Ehrbar, M van Overeem Felter, S Winther Hasler, T M Janssen, S L Risumlund, J E van Timmeren, I R Vogelius, C P Behrens
{"title":"PTV Margins in MR-guided and Beam-gated SBRT of Liver Metastases: GTV Dose Escalation Can Reduce the Required PTV.","authors":"I Wahlstedt, E van der Bijl, K Boye, S Ehrbar, M van Overeem Felter, S Winther Hasler, T M Janssen, S L Risumlund, J E van Timmeren, I R Vogelius, C P Behrens","doi":"10.1016/j.clon.2024.103736","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Determining appropriate PTV margins for SBRT of liver metastases is a non-trivial task, especially with motion management included. The widely used analytical van Herk margin recipe (van Herk et al., 2000) could break down due to (i) a low number of fractions, (ii) non-Gaussian errors, or (iii) non-homogenous dose distributions. We evaluated the validity of the analytical margin recipe in this setting for two very different guidelines for SBRT of liver metastases in three fractions - one with a relatively homogenous dose within the PTV (British) and one allowing much steeper dose gradients within the PTV (Danish).</p><p><strong>Materials and methods: </strong>We extracted sagittal motion traces for nineteen consecutive MR-guided and beam-gated treatments (57 fractions) on an MR-linac. We used these motion traces to calculate analytical van Herk GTV-to-PTV margins to account for intrafractional motion according to both British and Danish guidelines. We used the same motion traces to validate the analytical margins with motion-compensated dose accumulation in dose distributions obtained from British and Danish plans with varying PTV margins.</p><p><strong>Results: </strong>Analytical margins for the British guidelines were 2.4 mm superior-inferiorly (SI) and 3.2 mm anterior-posteriorly (AP). For the Danish guidelines, analytical margins were 1.7 mm SI and 2.7 mm AP. Dose accumulation validation showed that a margin of 3 mm SI and 1.5 mm AP would have been sufficient for British plans to ensure 95% of the prescription dose to at least 99% of the GTV in 90% of the treatments (same criterion as used in the analytical calculation) of the patients. No PTV margin was needed to achieve the same with Danish guidelines.</p><p><strong>Conclusion: </strong>GTV dose escalation can reduce the required motion-related PTV margins in SBRT with motion management. The van Herk margin recipe overestimates PTV margins in SBRT with inhomogeneous target dose distributions and becomes less applicable when the inhomogeneity increases.</p>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"39 ","pages":"103736"},"PeriodicalIF":3.2000,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clon.2024.103736","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Determining appropriate PTV margins for SBRT of liver metastases is a non-trivial task, especially with motion management included. The widely used analytical van Herk margin recipe (van Herk et al., 2000) could break down due to (i) a low number of fractions, (ii) non-Gaussian errors, or (iii) non-homogenous dose distributions. We evaluated the validity of the analytical margin recipe in this setting for two very different guidelines for SBRT of liver metastases in three fractions - one with a relatively homogenous dose within the PTV (British) and one allowing much steeper dose gradients within the PTV (Danish).

Materials and methods: We extracted sagittal motion traces for nineteen consecutive MR-guided and beam-gated treatments (57 fractions) on an MR-linac. We used these motion traces to calculate analytical van Herk GTV-to-PTV margins to account for intrafractional motion according to both British and Danish guidelines. We used the same motion traces to validate the analytical margins with motion-compensated dose accumulation in dose distributions obtained from British and Danish plans with varying PTV margins.

Results: Analytical margins for the British guidelines were 2.4 mm superior-inferiorly (SI) and 3.2 mm anterior-posteriorly (AP). For the Danish guidelines, analytical margins were 1.7 mm SI and 2.7 mm AP. Dose accumulation validation showed that a margin of 3 mm SI and 1.5 mm AP would have been sufficient for British plans to ensure 95% of the prescription dose to at least 99% of the GTV in 90% of the treatments (same criterion as used in the analytical calculation) of the patients. No PTV margin was needed to achieve the same with Danish guidelines.

Conclusion: GTV dose escalation can reduce the required motion-related PTV margins in SBRT with motion management. The van Herk margin recipe overestimates PTV margins in SBRT with inhomogeneous target dose distributions and becomes less applicable when the inhomogeneity increases.

磁共振引导和束控肝转移SBRT的PTV边缘:GTV剂量增加可以降低所需的PTV。
目的:为肝转移性SBRT确定合适的PTV切缘是一项不平凡的任务,特别是包括运动管理。广泛使用的分析van Herk边际配方(van Herk et al., 2000)可能由于(i)分数数量少,(ii)非高斯误差,或(iii)剂量分布不均匀而失效。在这种情况下,我们评估了两种截然不同的肝转移SBRT指南的分析边缘处方的有效性,分为三个部分——一个在PTV内的剂量相对均匀(英国),另一个在PTV内允许更陡峭的剂量梯度(丹麦)。材料和方法:我们在磁共振直线机上提取了19个连续的磁共振引导和束门治疗(57个部分)的矢状运动轨迹。我们使用这些运动轨迹来计算分析范赫尔克gtv - ptv边际,以根据英国和丹麦的指导方针来解释引力内运动。我们使用相同的运动轨迹来验证从英国和丹麦计划中获得的具有不同PTV边界的剂量分布中具有运动补偿剂量积累的分析边界。结果:英国指南的分析边缘为2.4 mm上下(SI)和3.2 mm前后(AP)。对于丹麦指南,分析边际为1.7 mm SI和2.7 mm AP。剂量累积验证表明,对于英国计划来说,3mm SI和1.5 mm AP的边际足以确保95%的处方剂量在90%的治疗中至少达到99%的GTV(与分析计算中使用的标准相同)。按照丹麦的指导方针,不需要PTV差值。结论:GTV剂量增加可以减少SBRT患者运动相关的PTV边界。van Herk边际公式高估了靶剂量分布不均匀的SBRT的PTV边际,当不均匀性增加时,该公式变得不适用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical oncology
Clinical oncology 医学-肿瘤学
CiteScore
5.20
自引率
8.80%
发文量
332
审稿时长
40 days
期刊介绍: Clinical Oncology is an International cancer journal covering all aspects of the clinical management of cancer patients, reflecting a multidisciplinary approach to therapy. Papers, editorials and reviews are published on all types of malignant disease embracing, pathology, diagnosis and treatment, including radiotherapy, chemotherapy, surgery, combined modality treatment and palliative care. Research and review papers covering epidemiology, radiobiology, radiation physics, tumour biology, and immunology are also published, together with letters to the editor, case reports and book reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信